• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Archives for January–April 2023

Individual Risk Assessment Questions for Potential Donors at Higher Risk for HIV

In January 2023, the U.S. FDA issued draft guidance recommending individual risk-based assessments for potential donors at higher risk for…

April 26, 2023

Randomized Trial Results on Donor Sex and RBC Recipient Mortality

Observational studies and systematic reviews have found conflicting results on the association between RBC donor sex and associated transfusion recipient…

April 18, 2023

Whole Blood Derived Platelet vs. Apheresis Platelets

During the COVID-19 pandemic, the U.S. experienced significant blood product shortages. In 2019, approximately 2.5 million platelet units were collected…

April 12, 2023

Seven-Day Platelet Storage and Platelet Count Increments

Platelets must be stored at room temperature to preserve function, which makes them susceptible to bacterial contamination.  Recently, several countries…

April 4, 2023

Prothrombin Complex Concentrate Increases Risk of Thromboembolic Events in Trauma Patients

Four-factor prothrombin complex concentrate (4F-PCC) is a lyophilized concentrate of coagulation factors that is commonly used for urgent reversal of…

March 29, 2023

FDA Guidance for COVID-19 Convalescent Plasma to Remain in Effect

During the public health emergency for COVID-19, the U.S. Food and Drug Administration (FDA) issued guidance for the use of…

March 22, 2023

Acute Normovolemic Hemodilution Reduces Transfusions in Patients Undergoing Cardiac Surgery

Approximately one to two million cardiac surgery operations are performed worldwide each year accounting for about 80% of all surgical…

March 15, 2023

Introducing IH-AbID: Bio-Rad’s Integrated Antibody Identification Software

Request educational materials or speak with a Bio-Rad specialist IH-AbID simplifies your complex, labor-intensive process of identifying antibodies to red…

March 10, 2023

Gene Therapy Phase 3 Study Results for Hemophilia B

Hemophilia B is a rare, X-linked bleeding disorder caused by partial or complete deficiency of clotting factor IX.  Currently, the…

March 8, 2023

High Variability in Antibody Titer Determination in Transfusion Medicine

Antibody levels are important for many aspects of clinical care from evaluating the incompatibility of transfusions and transplants to determining…

March 2, 2023

  • Page 1
  • Page 2
  • Next Page »

Primary Sidebar

Latest News

  • Babesia Infection Reduces Red Cell Deformability

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley